Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,774,965 | $19,361,138 | $22,473,408 | $15,932,820 |
| % Growth | -85.7% | -13.8% | 41.1% | – |
| Cost of Goods Sold | $2,328,366 | $16,307,665 | $17,863,643 | $13,869,027 |
| Gross Profit | $446,599 | $3,053,473 | $4,609,766 | $2,063,793 |
| % Margin | 16.1% | 15.8% | 20.5% | 13% |
| R&D Expenses | $22,237 | $141,572 | $143,713 | $185,257 |
| G&A Expenses | $0 | -$337,533 | $605,951 | -$1,190,699 |
| SG&A Expenses | $269,909 | -$682,483 | $2,192,584 | -$2,989,698 |
| Sales & Mktg Exp. | $0 | -$344,951 | $1,586,633 | -$1,798,999 |
| Other Operating Expenses | $11,525 | $2,795,221 | $46,102 | $5,272,909 |
| Operating Expenses | $303,670 | $2,254,310 | $2,382,398 | $2,468,467 |
| Operating Income | $142,928 | $799,163 | $2,227,367 | -$404,674 |
| % Margin | 5.2% | 4.1% | 9.9% | -2.5% |
| Other Income/Exp. Net | $10,573 | $60,266 | $3,620 | $6,217 |
| Pre-Tax Income | $153,501 | $859,430 | $2,230,987 | -$398,458 |
| Tax Expense | $38,104 | $140,956 | $373,538 | -$109,749 |
| Net Income | $111,427 | $694,828 | $1,821,313 | -$323,481 |
| % Margin | 4% | 3.6% | 8.1% | -2% |
| EPS | 0.069 | 0.43 | 1.12 | -0.2 |
| % Growth | -84.1% | -61.6% | 660% | – |
| EPS Diluted | 0.069 | 0.43 | 1.12 | -0.2 |
| Weighted Avg Shares Out | 1,625,791 | 1,626,173 | 1,626,173 | 1,625,791 |
| Weighted Avg Shares Out Dil | 1,625,791 | 1,626,173 | 1,626,173 | 1,625,791 |
| Supplemental Information | – | – | – | – |
| Interest Income | $17,330 | $36,719 | $48,078 | $80,535 |
| Interest Expense | $14,303 | $102,387 | $101,614 | $100,677 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $167,690 | $961,816 | $2,332,601 | -$297,781 |
| % Margin | 6% | 5% | 10.4% | -1.9% |